Hepatitis C in children co-infected with human immunodeficiency virus

Journal of Pediatric Gastroenterology and Nutrition

Volumn 61, Issue 4, 2015, Pages 393-399

  Indolfi, Giuseppe ^a   Bartolini, Elisa ^a   Serranti, Daniele ^b   Azzari, Chiara ^b   Resti, Massimo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cirrhosis; Direct acting antiviral agents; Pegylated interferon; Ribavirin; Treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PEGINTERFERON ALPHA; RIBAVIRIN; ANTIVIRUS AGENT;

CHILDHOOD DISEASE; CLINICAL FEATURE; DRUG EFFICACY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LABORATORY TEST; LIVER INJURY; MEDICAL HISTORY; MIXED INFECTION; OUTCOME ASSESSMENT; PHYSICAL DISEASE BY BODY FUNCTION; PRIORITY JOURNAL; PUBLICATION; REVIEW; SYSTEMATIC REVIEW; VERTICAL TRANSMISSION; VIRAL CLEARANCE; VIREMIA; ANTIVIRAL RESISTANCE; ASYMPTOMATIC INFECTION; CHILD; COMPLICATION; DISEASE COURSE; DRUG EFFECTS; FEMALE; HEPATITIS C, CHRONIC; HIV INFECTIONS; INFANT; LIVER; LIVER CIRRHOSIS; MALE; NEWBORN; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRESCHOOL CHILD; PREVENTION AND CONTROL; TRANSMISSION; VIROLOGY;

ANTI-HIV AGENTS; ANTIVIRAL AGENTS; ASYMPTOMATIC INFECTIONS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DRUG RESISTANCE, VIRAL; FEMALE; HEPATITIS C; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LIVER; LIVER CIRRHOSIS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84942512383     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000000895     Document Type: Review

References (55)

1. Bortolotti F, Verucchi G, Camma C, et al. Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology 2008;134:1900-7.
2. Papaevangelou V, Pollack H, Rochford G, et al. Increased transmission of vertical hepatitis C virus (HCV) infection to human immunodeficiency virus (HIV)-infected infants of HIV- and HCV-coinfected women. J Infect Dis 1998;178:1047-52.
3. Thomas DL, Villano SA, Riester KA, et al. Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study. J Infect Dis 1998; 177:1480-8.
4. Indolfi G, Azzari C, Resti M. Perinatal transmission of hepatitis C virus. J Pediatr 2013;163:1549-52.
5. Benova L, Mohamoud YA, Calvert C, et al. Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clin Infect Dis 2014;59:765-73.
6. Mast EE, Hwang LY, Seto DS, et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCVinfection acquired in infancy. J Infect Dis 2005;192:1880-9.
7. Mariné-Barjoan E, Berrébi A, Giordanengo V, et al. HCV/HIV coinfection, HCV viral load and mode of delivery: risk factors for motherto- child transmission of hepatitis C virus? AIDS 2007;21:1811-5.
8. European Paediatric Hepatitis C Virus Network. A significant sex-but not elective cesarean section-effect on mother-to-child transmission of hepatitis C virus infection. J Infect Dis 2005;192:1872-9.
9. Nigro G, D'Orio F, Catania S, et al. Mother to infant transmission of coinfection by human immunodeficiency virus and hepatitis C virus: prevalence and clinical manifestations. Arch Virol 1997;142:453-7.
10. Tovo PA, Palomba E, Ferraris G, et al. Increased risk of maternal-infant hepatitis C virus transmission for women coinfected with human immunodeficiency virus type 1. Italian Study Group for HCV Infection in Children. Clin Infect Dis 1997;25:1121-4.
11. Zanetti AR, Tanzi E, Romano L, et al. A prospective study on mother-toinfant transmission of hepatitis C virus. Intervirology 1998;41:208-12.
12. Gibb DM, Goodall RL, Dunn DT, et al. Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet 2000;356:904-7.
13. Ferrero S, Lungaro P, Bruzzone BM, et al. Prospective study of motherto- infant transmission of hepatitis C virus: a 10-year survey (1990- 2000). Acta Obstet Gynecol Scand 2003;82:229-34.
14. Paccagnini S, Principi N, Massironi E, et al. Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population. Pediatr Infect Dis J 1995;14:195-9.
15. European Paediatric Hepatitis C Virus Network. Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus. European Paediatric Hepatitis C Virus Network. BJOG 2001;108:371-7.
16. Resti M, Azzari C, Galli L, et al. Maternal drug use is a preeminent risk factor for mother-to-child hepatitis C virus transmission: results from a multicenter study of 1372 mother-infant pairs. J Infect Dis 2002; 185:567-72.
17. Resti M, Azzari C, Moriondo M, et al. Injection drug use facilitates hepatitis C virus infection of peripheral blood mononuclear cells. Clin Infect Dis 2002;35:236-9.
18. Azzari C, Resti M, Moriondo M, et al. Vertical transmission of HCV is related to maternal peripheral blood mononuclear cell infection. Blood 2000;96:2045-8.
19. Azzari C, Moriondo M, Indolfi G, et al. Higher risk of hepatitis C virus perinatal transmission from drug user mothers is mediated by peripheral blood mononuclear cell infection. J Med Virol 2008;80:65-71.
20. Zanetti AR, Tanzi E, Paccagnini S, et al. Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCV Transmission. Lancet 1995;345:289-91.
21. Resti M, Azzari C, Mannelli F, et al. Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus Infection. BMJ 1998;317:437-41.
22. Chiappini E, Galli L, Giaquinto C, et al. Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants. AIDS 2013;27:991-1000.
23. Hershow RC, Riester KA, Lew J, et al. Increased vertical transmission of human immunodeficiency virus from hepatitis C virus-coinfected mothers. Women and Infants Transmission Study. J Infect Dis 1997; 176:414-20.
24. Indolfi G, Moriondo M, Galli L, et al. Mother-to-infant transmission of multiple blood-borne viral infections from multi-infected mothers. J Med Virol 2007;79:743-7.
25. Indolfi G, Mangone G, Calvo PL, et al. Interleukin 28B rs12979860 single-nucleotide polymorphism predicts spontaneous clearance of hepatitis C virus in children. J Pediatr Gastroenterol Nutr 2014; 58:666-8.
26. Indolfi G, Mangone G, Bartolini E, et al. Comparative analysis of rs12979860 SNP of the IFNL3 gene in children with hepatitis C and ethnic matched controls using 1000 Genomes Project data. PLoS One 2014;9:e85899.
27. European Paediatric Hepatitis C Virus Network. Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clin Infect Dis 2005;41:45-51.
28. Mohan P, Barton BA, Narkewicz MR, et al. Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C: a retrospective study. Hepatology 2013;58:1580-6.
29. Macías J, Berenguer J, Japón MA, et al. Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus. Hepatology 2009;50: 1056-63.
30. Braü N, Fox RK, Xiao P, et al. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. J Hepatol 2007;47:527-37.
31. LinW,Weinberg EM, Chung RT. Pathogenesis of accelerated fibrosis in HIV/HCV co-infection. J Infect Dis 2013;207:S13-8.
32. Claret-Teruel G, Noguera-Julian A, Esteva C, et al. Impact of human immunodeficiency virus coinfection on the progression of mother-tochild transmitted hepatitis C virus infection. Pediatr Infect Dis J 2011;30:801-4.
33. Tenckhoff S, Kaiser T, Bredeek F, et al. Role of GB virus C in HIV-1- infected and hepatitis C virus-infected hemophiliac children and adolescents. J Acquir Immune Defic Syndr 2012;61:243-8.
34. Daar ES, Lynn H, Donfield S, et al. Relation between HIV-1 and hepatitis C viral load in patients with hemophilia. J Acquir Immune Defic Syndr 2001;26:466-72.
35. Micheloud D, Jensen J, Bellón JM, et al. Slow progression of human immunodeficiency virus and hepatitis C virus disease in a cohort of coinfected children. Pediatr Infect Dis J 2007;26:846-9.
36. Zhou S, Zhao Y, He Y, et al. Hepatitis B and hepatitis C seroprevalence in children receiving antiretroviral therapy for human immunodeficiency virus-1 infection in China, 2005-2009. J Acquir Immune Defic Syndr 2010;54:191-6.
37. Ejeliogu EU, Oguche S, Ebonyi AO, et al. Human immunodeficiency virus and hepatitis C virus co-infection in children in Jos, Nigeria. Open Science J Clin Med 2014;2:69-72.
38. Dapena M, Figueras C, Noguera-Julian A, et al. Implementation of occult hepatitis screening in the Spanish cohort of HIV-infected pediatric patients. Pediatr Infect Dis J 2013;32:e377-9.
39. Schuval S, Van Dyke RB, Lindsey JC, et al. Hepatitis C prevalence in children with perinatal human immunodeficiency virus infection enrolled in a long-term follow-up protocol. Arch Pediatr Adolesc Med 2004;158:1007-13.
40. Quesnel-Vallieres M, Lemay M, Lapointe N, et al. HCV quasispecies evolution during treatment with interferon alfa-2b and ribavirin in two children coinfected with HCVand HIV-1. J Clin Virol 2008;43:236-40.
41. Turkova A, European Paediatric HIV/HCV Co-infection Study Group in European Pregnancy and Paediatric HIV Cohort Collaboration. Uptake and outcomes of HCV treatment in children and young adults with HIV/HCV co-infection in Europe. Presented at: 20th International AIDS Conference, Melbourne, Australia, July 20-25, 2014.
42. de Lédinghen V, Le Bail B, Rebouissoux L, et al. Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr 2007;45:443-50.
43. Nobili V, Vizzutti F, Arena U, et al. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 2008;48:442-8.
44. Li Vecchi V, Giannitrapani L, Di Carlo P, et al. Non-invasive assessment of liver steatosis and fibrosis in HIV/HCV- and HCV-infected patients. Ann Hepatol 2013;12:740-8.
45. Núñez M. Clinical syndromes and consequences of antiretroviral-related hepatotoxicity. Hepatology 2010;52:1143-55.
46. Rosso R, Di Biagio A, Mikulska M, et al. Safety and efficacy of pegylated interferon and ribavirin in adolescents with human immunodeficiency virus and hepatitis C virus acquired perinatally. J Med Virol 2010;82:1110-4.
47. Escobar-Gutiérrez A, Soudeyns H, Larouche A, et al. Vertical transmission of hepatitis C virus: a tale of multiple outcomes. Infect Genet Evol 2013;20:465-70.
48. Rodriguez-Torres M, Slim J, Bhatti L, et al. Peginterferon alfa-2a plus ribavirin for HIV-HCV genotype 1 coinfected patients: a randomized international trial. HIV Clin Trials 2012;13:142-52.
49. Torriani FJ, Rodriguez-Torres M, et al. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 2004;351:438-50.
50. Sulkowski MS, Sherman KE, Dieterich DT, et al. Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial. Ann Intern Med 2013;159:86-96.
51. Sulkowski M, Pol S, Cooper C, et al. Boceprevir plus peginterferon/ribavirin for the treatment of HCV/HIV co-infected patients. Presented at: 19th Conference on Retroviruses and Opportunistic Infections; March 5-8, 2011; Seattle, WA. Abstract 47.
52. Osinusi A, Townsend K, Kohli A, et al. Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection. JAMA 2015;313:1232-9.
53. Sulkowski MS, Eron JJ, Wyles D, et al. Ombitasvir, paritaprevir codosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial. JAMA 2015;313:1223-31.
54. Molina JM, Orkin C, Iser DM, et al. Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study. Lancet 2015;385:1098-106.
55. England K, Thorne C, Castelli-Gattinara G, et al. HIV and HCV progression in parenterally coinfected children. Curr HIV Res 2009; 7:346-53.